Patents by Inventor Mohamend El-Sherbeini

Mohamend El-Sherbeini has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MurC gene and enzyme of
    Patent number: 7022829
    Abstract: This invention provides isolated polynucleotides that encode the MurC protein of Pseudomonas aeruginosa. Purified and isolated MurC recombinant proteins are also provided. Nucleic acid sequences which encode functionally active MurC proteins are described. Assays for the identification of modulators of the of expression of murC and inhibitors of the activity of MurC, are also provided.
    Type: Grant
    Filed: September 11, 2000
    Date of Patent: April 4, 2006
    Assignee: Merck & Co., Inc.
    Inventors: Mohamend El-Sherbeini, Barbara Azzolina
  • Murf gene and enzyme of Pseudomonas aeruginosa
    Patent number: 6949336
    Abstract: This invention provides isolated polynucleotides that encode the MurF (UDP-N-acetylmuramyl-L-alanine-D-glutamate-m-DaD:D-alanine-D-alanine ligase) protein of Pseudomonas aeruginosa. Purified and isolated MurF recombinant proteins are also provided. Nucleic acid sequences which encode functionally active MurF proteins are described. Assays for the identification of modulators of the expression of murF and inhibitors of the activity of MurF, are also provided.
    Type: Grant
    Filed: September 6, 2000
    Date of Patent: September 27, 2005
    Assignee: Merck & Co., Inc.
    Inventors: Mohamend El-Sherbeini, Barbara Azzolina
  • MurE protein and gene of pseudomonas aeruginosa
    Patent number: 6870041
    Abstract: This invention provides isolated polynucleotides that encode the MurE protein of Pseudomonas aeruginosa. Purified and isolated MurE recombinant proteins are also provided. Nucleic acid sequences which encode functionally active MurE proteins are described. Assays for the identification of modulators of the of expression of murE and inhibitors of the activity of MurE, are also provided.
    Type: Grant
    Filed: September 11, 2000
    Date of Patent: March 22, 2005
    Assignee: Merck & Co., Inc.
    Inventors: Mohamend El-Sherbeini, Barbara Azzolina